股票 › VSTM
维拉斯特姆肿瘤 VSTM
美股市值排名 #3177
$8.41 −$0.97 (-10.34%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $8.41 0.00%
开盘$8.66
昨收$9.38
当日区间$7.72 – $8.86
成交量7.04M
市值$1.06B
市盈率（TTM）–
股息率–
VSTM 相关新闻
匹配 Verastem 或代码 VSTM 的头条新闻，按最新排序。
- RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $14
- Wolfe Research Maintains Verastem(VSTM.US) With Buy Rating
- A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $12 to $18
- Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $13 负面
- RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14 负面
- A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $14 to $18
- Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Madrigal Pharmaceuticals (MDGL) and Verastem (VSTM)
- A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $8 to $18
- Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $14
- BTIG Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $18 负面
- H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)
- RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $15
- H.C. Wainwright Sticks to Their Buy Rating for Verastem (VSTM)
- Verastem (VSTM) Receives a Buy From B. Riley Securities
- Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14 负面
暂无评论——快来第一个聊聊 VSTM。
登录后参与讨论。